HeartSciences is advancing the field of electrocardiography through the application of wavelet signal processing and artificial intelligence to develop next-generation ECG technology. Wavelet signal processing is currently used in many different industries as an important tool to provide insights and new valuable data related to spectral analysis of a signal. HeartSciences’ MyoVista wavECG Cardiac Testing Device is a 12-lead resting electrocardiograph utilizing continuous wavelet transform (CWT) based signal processing. Patented informatics focus on energy-related information rather than conventional voltage-based information. HeartSciences' mission is to enable accurate, affordable screening for the early detection of heart disease.
B2B2C, B2B
51 to 100
Funded
$28,198,000
Scaling Up
2008
Medical Devices
Healthcare
N/A
Increase Efficiency
Healthcare
Service
Yes
Active
Machine Learning
Machine Perception
Software & Hardware
N/A
Potential Customers
Interested in what they do or partnership?
Learn more about how they work
